Several questions about the origin of the outbreak remain with no clear data on what this was or if it was an animal source.
Academic rigour, journalistic flair
Articles on COVID-19
Displaying 7781 - 7800 of 7942 articles
A first-century B.C. Roman poet and philosopher, Lucretius was worried that our fear of death could lead to irrational beliefs and actions that could harm society.
A molecular biologist explains who should get tested, how the tests work and what the US government is doing to make tests available during a rapidly changing crisis.
The US blood supply chain is often fragile, but the coronavirus could make it more so. An expert explains.
Could the Olympic Games be postponed for the first time in its history?
Cash payments are much more likely to be spent than bonus tax refunds.
When a health crisis is the driver of an economic crisis, the uncertainties are multiplied, and people’s reactions are more difficult to predict.
The coronavirus outbreak is causing people to rethink the handshake and seek other gestures that perform similar functions without touch.
There are several things Australian schools can do, that involve encouraging better hygiene and social distancing. They could close too, but that’s not always necessary.
Not everyone who wants a telehealth consultation with their doctor over the next six months will be eligible for one.
The attempts at product differentiation that preceded the $18 billion program are all but exhausted.
The government has announced it’s $17.6 billion stimulus package, focused on investment in business, boosting cashflow, and putting cash in the hands of lower income earners.
Best-case estimates suggest 40 million American adults may come down with COVID-19. But an epidemiologist explains why now is not the time to just give up.
An online education expert explains the challenges schools will face as they go virtual.
It is the stories that are entertaining rather than informative that are most likely to add to the panic, and media outlets need to be careful about what they publish.
How do we develop new drugs quickly yet safely? How prepared are we to give up some personal freedoms? And how do we allocate scarce resources? These are just some of the tough questions we face.
Remote working is about to surge as companies around the world advise employees to stay away in response to the coronavirus outbreak. But nothing beats the effectiveness of face-to-face interactions.
For higher ed, this is a crisis of unknown proportions.
Don’t count on it, says virologist.
The new chancellor’s plans won’t look half as prudent if the economy tanks.
Top contributors
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Economics, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Senior Research Fellow in Global Health, University of Southampton
-
Professor of Medicine, University of East Anglia
-
Associate professor, UNSW Sydney
-
Professor of Public Health, University of Sheffield
-
Professor of Medicine, University of Virginia
-
Associate Professor of Bioethics, University of Portsmouth
